Detalhe da pesquisa
1.
STMN1 as a novel prognostic biomarker in HCC correlating with immune infiltrates and methylation.
World J Surg Oncol;
20(1): 301, 2022 Sep 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36127700